Acute chest syndrome natural history, complications and prognosis

Jump to: navigation, search

Acute chest syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Acute chest syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute chest syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute chest syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute chest syndrome natural history, complications and prognosis

CDC on Acute chest syndrome natural history, complications and prognosis

Acute chest syndrome natural history, complications and prognosis in the news

Blogs on Acute chest syndrome natural history, complications and prognosis

Directions to Hospitals Treating Acute chest syndrome

Risk calculators and risk factors for Acute chest syndrome natural history, complications and prognosis

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Natural History, Complications and Prognosis

  • Overall mortality in patients with ACS is 1.8%, however in adults the rate is 4.3%.
  • There is no difference between patients with Hb SS and Hb SC.
  • Unfortunately, there have been no presenting signs, symptoms or laboratory data that is predictive of who will die.
  • A trend to increased mortality has been observed in patients with a lower presenting hemoglobin, multilobar involvement on CXR, and bacteremia.
  • Patients who die, tend to do so very rapidly and unexpectedly.

References



Linked-in.jpg